Pay in 4 interest-free payments of $10.50 Learn more
Ships within 48 hours · Estimated delivery Aug 1 - Aug 6
NVP-TAE684 suppresses lymphomagenesis in two independent models of ALK-positive ALCL and induces regression of established Karpas-299 lymphomas
Fatostatin A can prevent increases in body weight
5 MTD dose of Bortezomib (0
Formula: C14H19BCl2N2O4
with mean decreases of 2
UK-5099 - CAS# 56396-35-1 66052 NVP-TAE684 suppresses lymphomagenesis in twoUK 5099, CAS No. 56396 35 1, is a specific and potent mitochondrial pyruvate carrier blocker (MCK blocker). The UK5099 treated cells showed significantly higher proportion of side population (SP) fraction and expressed higher levels of stemness markers Oct3 4 and Nanog. Chemosensitivity examinations revealed that the UK5099 treated cells became more resistant to chemotherapy compared to the non treated cells. MPC blocker (UK5099) application may be an